CN100580079C - 神经祖细胞群体 - Google Patents
神经祖细胞群体 Download PDFInfo
- Publication number
- CN100580079C CN100580079C CN01809662A CN01809662A CN100580079C CN 100580079 C CN100580079 C CN 100580079C CN 01809662 A CN01809662 A CN 01809662A CN 01809662 A CN01809662 A CN 01809662A CN 100580079 C CN100580079 C CN 100580079C
- Authority
- CN
- China
- Prior art keywords
- cell
- colony
- differentiation
- cells
- neural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
Abstract
Description
Claims (25)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20560000P | 2000-05-17 | 2000-05-17 | |
US60/205,600 | 2000-05-17 | ||
US25760800P | 2000-12-22 | 2000-12-22 | |
US60/257,608 | 2000-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1429267A CN1429267A (zh) | 2003-07-09 |
CN100580079C true CN100580079C (zh) | 2010-01-13 |
Family
ID=26900583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01809662A Expired - Fee Related CN100580079C (zh) | 2000-05-17 | 2001-05-16 | 神经祖细胞群体 |
Country Status (11)
Country | Link |
---|---|
US (6) | US20020009743A1 (zh) |
EP (1) | EP1287116A2 (zh) |
JP (5) | JP5943533B2 (zh) |
KR (1) | KR100903755B1 (zh) |
CN (1) | CN100580079C (zh) |
AU (2) | AU6319901A (zh) |
CA (1) | CA2409698C (zh) |
GB (1) | GB2379447B (zh) |
HK (1) | HK1055765A1 (zh) |
IL (2) | IL152741A0 (zh) |
WO (1) | WO2001088104A2 (zh) |
Families Citing this family (203)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410798B2 (en) * | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
CA2371260A1 (en) | 1999-05-03 | 2000-11-09 | Karolinska Innovations Ab | Materials and methods relating to neuronal development |
US20030087263A1 (en) * | 1999-12-16 | 2003-05-08 | Renu Wadhwa | Method of screening remedy for cancer with the use of interaction domain of p53 and mortalin |
US20050042749A1 (en) | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
IL151170A0 (en) | 2000-03-14 | 2003-04-10 | Es Cell Int Pte Ltd | Embryonic stem cells and neural progenitor cells derived therefrom |
US7011828B2 (en) * | 2000-03-14 | 2006-03-14 | Es Cell International Pte. Ltd. | Implanting neural progenitor cells derived for human embryonic stem cells |
JP5943533B2 (ja) | 2000-05-17 | 2016-07-06 | アステリアス バイオセラピューティクス インコーポレイテッド | 神経前駆細胞の集団 |
US7250294B2 (en) * | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
US6576464B2 (en) * | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
US6921665B2 (en) * | 2000-11-27 | 2005-07-26 | Roslin Institute (Edinburgh) | Selective antibody targeting of undifferentiated stem cells |
JP3763749B2 (ja) * | 2001-03-28 | 2006-04-05 | 独立行政法人科学技術振興機構 | 脊髄におけるシナプス形成ニューロンを誘導する中枢神経系前駆細胞 |
US7943376B2 (en) | 2001-04-27 | 2011-05-17 | Stem Cell Therapuetics Inc. | Platelet derived growth factor (PDGF)-derived neurospheres define a novel class of progenitor cells |
CN101029302B (zh) * | 2001-06-21 | 2011-03-30 | 杰龙公司 | 用于治疗帕金森病的多巴胺能神经元和具有增殖能力的前体细胞 |
JP3886346B2 (ja) * | 2001-06-22 | 2007-02-28 | サンバイオ,インコーポレイティド | 骨髄間質細胞由来Schwann細胞を含む神経再生用医薬組成物 |
DE10134667A1 (de) * | 2001-07-20 | 2003-02-06 | Neuroprogen Gmbh Leipzig | Verfahren zur Herstellung isolierter Zellkulturen, Kulturmedium zur Kultivierung von Zellkulturen und Zellkultur |
US8153424B2 (en) * | 2001-10-03 | 2012-04-10 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US6887706B2 (en) | 2001-10-03 | 2005-05-03 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells |
US7588937B2 (en) | 2001-10-03 | 2009-09-15 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US7129034B2 (en) * | 2001-10-25 | 2006-10-31 | Cedars-Sinai Medical Center | Differentiation of whole bone marrow |
KR20130072272A (ko) | 2001-12-07 | 2013-07-01 | 제론 코포레이션 | 인간 배아 줄기세포 유래의 조혈세포 |
JP4374469B2 (ja) * | 2002-01-09 | 2009-12-02 | 独立行政法人科学技術振興機構 | 記憶障害治療剤 |
WO2003060082A2 (en) | 2002-01-14 | 2003-07-24 | The Board Of Trustees Of The University Of Illinois | Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
JP2006503543A (ja) * | 2002-01-23 | 2006-02-02 | ユニバーシティー オブ ユタ リサーチ ファンデーション | 星状細胞限定前駆細胞の純粋集団並びにその単離方法および使用 |
JP2005523012A (ja) * | 2002-04-16 | 2005-08-04 | デイナ−ファーバー キャンサー インスティチュート,インコーポレイテッド | 癌モデル |
EP1511839A4 (en) * | 2002-06-05 | 2005-11-16 | Es Cell Int Pte Ltd | GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENCED HUMAN EMBRYONAL STEM CELLS |
AU2003229132B9 (en) * | 2002-06-05 | 2009-07-23 | Es Cell International Pte Ltd | Generation of neural stem cells from undifferentiated human embryonic stem cells |
US7285415B2 (en) * | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US20050101014A1 (en) | 2002-07-11 | 2005-05-12 | Keirstead Hans S. | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US7632679B2 (en) * | 2002-07-16 | 2009-12-15 | The Trustees Of Columbia University In The City Of New York | Systems and methods for screening for modulators of neural differentiation |
US20040224302A1 (en) * | 2002-07-16 | 2004-11-11 | Thomas Jessel | Systems and methods for screening for modulators of neural differentiation |
WO2004029229A2 (en) * | 2002-09-24 | 2004-04-08 | Neuro Therapeutics Ab | Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
WO2004029203A2 (en) * | 2002-09-25 | 2004-04-08 | Bresagen, Inc. | Compositions and methods for enrichment of neural stem cells using ceramide analogs |
WO2004042018A2 (en) * | 2002-11-01 | 2004-05-21 | The Regents Of The University Of Colorado | Dopamine neurons from human embryonic stem cells |
US20050265983A1 (en) * | 2002-11-17 | 2005-12-01 | Eldad Melamed | Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
EP1576134B1 (en) * | 2002-12-09 | 2013-03-06 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
EP2457999B1 (en) * | 2002-12-16 | 2018-10-17 | Technion Research & Development Foundation Ltd. | Culture medium for pluripotent stem cells |
US20060211111A1 (en) * | 2002-12-18 | 2006-09-21 | Maisam Mitalipova | Compositions and methods for neural cell production and stabilization |
US8642332B2 (en) * | 2003-03-07 | 2014-02-04 | Cornell Research Foundation, Inc. | Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain |
AU2004219851B2 (en) * | 2003-03-12 | 2009-12-17 | Reliance Life Sciences Pvt. Ltd. | Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
ZA200401646B (en) * | 2003-03-12 | 2004-06-07 | Reliance Life Sciences Pvt Ltd | Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells. |
US7153650B2 (en) | 2003-03-13 | 2006-12-26 | Geron Corporation | Marker system for preparing and characterizing high-quality human embryonic stem cells |
US20060183221A1 (en) * | 2003-03-31 | 2006-08-17 | Schulz Thomas C | Method for neural differentiation of embryonic stem cells using protease passaging techniques |
US20070020608A1 (en) * | 2003-05-08 | 2007-01-25 | Peter Eriksson | Method for the generation of neural progenitor cells |
EP1702062A2 (en) * | 2003-06-11 | 2006-09-20 | Jan Remmereit | Differentiation of stem cells for therapeutic use |
CA2527847C (en) * | 2003-06-12 | 2015-09-29 | Yeda Research & Development Co. Ltd | Enhancement of oligodendrocyte differentiation |
KR20080109943A (ko) * | 2003-08-29 | 2008-12-17 | 위스콘신 얼럼나이 리서어치 화운데이션 | 영장류 배아 줄기 세포 기원의 신경 줄기 세포, 운동 뉴런 및 도파민 뉴런의 시험관내 분화 방법 |
US7820439B2 (en) | 2003-09-03 | 2010-10-26 | Reliance Life Sciences Pvt Ltd. | In vitro generation of GABAergic neurons from pluripotent stem cells |
EP1670897A4 (en) * | 2003-09-24 | 2008-02-27 | Univ Leland Stanford Junior | IGF-1 MULTIPOTENTE ADULTS HAS NEW NEURAL CNS STEM CELLS INTO AN OLIGOD DROGLIA CELLINE |
US20070269412A1 (en) | 2003-12-02 | 2007-11-22 | Celavie Biosciences, Llc | Pluripotent cells |
AU2004309300B8 (en) | 2003-12-30 | 2009-03-26 | Seoul National University Industry Foundation | Embryonic stem cell line and method for preparing the same |
WO2005079250A2 (en) * | 2004-02-13 | 2005-09-01 | Cornell Research Foundation, Inc. | Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom |
JP5226928B2 (ja) * | 2004-04-16 | 2013-07-03 | 株式会社カネカ | 細胞の分化転換方法 |
US20050272149A1 (en) * | 2004-06-02 | 2005-12-08 | Life & Brain Gmbh | Therapeutic delivery of adenosine into a tissue |
CN103146649B (zh) | 2004-06-09 | 2018-05-22 | 爱丁堡大学管理处 | 神经干细胞 |
CA2573437C (en) | 2004-07-13 | 2016-04-05 | Geron Corporation | Medium for growing human embryonic stem cells |
EP2269461B1 (en) * | 2004-07-30 | 2017-03-22 | Mayo Foundation For Medical Education And Research | Treating cardiovascular tissue |
US7547525B2 (en) * | 2004-08-12 | 2009-06-16 | Neuro Probe Incorporated | Point source diffusion cell activity assay |
US20060040389A1 (en) * | 2004-08-17 | 2006-02-23 | Murry Charles E | Purified compositions of stem cell derived differentiating cells |
KR20070047836A (ko) * | 2004-09-06 | 2007-05-07 | 다나베 세이야꾸 가부시키가이샤 | 성상세포-유사 세포의 조건 배지 제조 방법 |
WO2006044204A2 (en) * | 2004-10-05 | 2006-04-27 | University Of Georgia Research Foundation, Inc. | Neuronal progenitors from feeder-free human embryonic stem cell culture |
US8192988B2 (en) | 2004-10-22 | 2012-06-05 | University Of Central Florida Research Foundation, Inc. | Methods for increasing potency of adult mesenchymal stem cells |
US7629169B2 (en) | 2004-12-01 | 2009-12-08 | Stem Cell Therapeutics Corp. | Methods for the production of platelet-derived growth factor-responsive neural precursor cells |
WO2006073966A1 (en) * | 2004-12-30 | 2006-07-13 | Stemlifeline, Inc. | Methods and systems relating to embryonic stem cell lines |
WO2006073911A1 (en) * | 2004-12-30 | 2006-07-13 | Stemlifeline, Inc. | Methods and compositions relating to embryonic stem cell lines |
WO2006072005A2 (en) * | 2004-12-30 | 2006-07-06 | The Johns Hopkins University | Methods for high efficiency survival/proliferation of human embyonic stem cells and human embyro survival in culture |
EP1856248A4 (en) * | 2005-02-09 | 2010-01-20 | Burnham Inst Medical Research | HOMOGENEOUS NEURALE CURRENT CELLS |
CN101605552A (zh) | 2005-03-07 | 2009-12-16 | 桑比欧公司 | 神经元前体细胞用于治疗中枢神经系统损伤的用途 |
DK1893747T3 (en) | 2005-06-16 | 2014-12-01 | Univ Ramot | ISOLATED CELLS AND POPULATIONS INCLUDING SUCH CELLS FOR TREATING CNS DISEASES |
US20060292694A1 (en) * | 2005-06-22 | 2006-12-28 | Roslin Institute | Reporter hepatocytes and other cells for drug screening and toxicity testing |
US20060292695A1 (en) * | 2005-06-22 | 2006-12-28 | Roslin Institute | Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells |
EP1893749A1 (en) * | 2005-06-22 | 2008-03-05 | Geron Corporation | Reporter hepatocytes and other cells for drug screening and toxicity testing |
KR20080030039A (ko) * | 2005-06-22 | 2008-04-03 | 제론 코포레이션 | 인간 배아 줄기 세포의 현탁 배양 |
EP1904843A2 (en) * | 2005-07-08 | 2008-04-02 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
CN101351544B (zh) * | 2005-08-26 | 2013-06-12 | 罗切斯特大学 | 胶质限制性前体衍生的星形胶质细胞移植以促进轴突生长 |
SG177946A1 (en) | 2005-08-29 | 2012-02-28 | Technion Res & Dev Foundation | Media for culturing stem cells |
KR20080056181A (ko) | 2005-09-02 | 2008-06-20 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 전구세포주의 유도 방법 |
US8986676B2 (en) | 2005-11-10 | 2015-03-24 | Genervon Biopharmaceuticals Llc | MNTF differentiation and growth of stem cells |
WO2007066338A1 (en) * | 2005-12-08 | 2007-06-14 | Ramot At Tel Aviv University Ltd. | Isolated oligodendrocyte-like cells and populations comprising same for the treatment of cns diseases |
US8278104B2 (en) * | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
PT1970446E (pt) | 2005-12-13 | 2011-09-01 | Univ Kyoto | Factor de reprogramação nuclear |
US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
KR100683199B1 (ko) | 2006-01-09 | 2007-02-15 | 주식회사 휴림바이오셀 | 신경전구세포를 콜린성 신경세포로 분화시키는 방법 및그에 사용되는 배지 |
KR100683198B1 (ko) | 2006-01-09 | 2007-02-15 | 주식회사 휴림바이오셀 | 신경전구세포를 도파민성 신경세포로 분화시키는 방법 및그에 사용되는 배지 |
US20090175835A1 (en) * | 2006-02-07 | 2009-07-09 | Korea Institute Of Radiological & Medical Sciences | Composition for treating damage of central or peripheral nerve system |
KR100838013B1 (ko) * | 2006-06-07 | 2008-06-12 | 제일약품주식회사 | 인간배아줄기세포로부터 단계적 선별법을 통해 고수율로신경전구세포, 신경세포 및 기능성 도파민신경세포를생성하는 방법 |
US20080003676A1 (en) * | 2006-06-26 | 2008-01-03 | Millipore Corporation | Growth of embryonic stem cells |
US9765298B2 (en) * | 2006-07-24 | 2017-09-19 | Mayo Foundation For Medical Education And Research | Methods and materials for providing cardiac cells |
US9040297B2 (en) | 2006-08-02 | 2015-05-26 | Technion Research & Development Foundation Limited | Methods of expanding embryonic stem cells in a suspension culture |
WO2008100168A1 (en) * | 2007-02-16 | 2008-08-21 | Universidade De Coimbra | Method for the functional identification of new neurons, neural progenitors, astrocytes and immature cells from stem cell cultures and uses thereof |
WO2008127974A1 (en) * | 2007-04-13 | 2008-10-23 | The Trustees Of Columbia University In The City Of New York | Stem cell-based culture system for drug development |
US9213999B2 (en) | 2007-06-15 | 2015-12-15 | Kyoto University | Providing iPSCs to a customer |
US9029147B2 (en) * | 2007-06-15 | 2015-05-12 | Massachusetts Institute Of Technology | Methods and compositions for enhanced differentiation from embryonic stem cells |
JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
WO2009058451A2 (en) * | 2007-08-02 | 2009-05-07 | California Stem Cell, Inc. | Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells |
KR100941036B1 (ko) | 2007-10-05 | 2010-02-05 | 고려대학교 산학협력단 | 인간 배아줄기세포로부터 척수신경계 희소돌기 아교세포생산을 위한 삼단계 분화기법 |
WO2009066817A1 (en) * | 2007-11-23 | 2009-05-28 | Seoul National University Industry Foundation | Method for inducing differentiation of human mesenchymal stem cells into motor neurons |
CA2714010C (en) | 2008-01-30 | 2020-06-16 | Corning Incorporated | Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
SG10201400329YA (en) | 2008-05-02 | 2014-05-29 | Univ Kyoto | Method of nuclear reprogramming |
WO2009145761A1 (en) * | 2008-05-27 | 2009-12-03 | Mayo Foundation For Medical Education And Research | Methods and materials for using cells to treat heart tissue |
ES2729557T3 (es) | 2008-05-28 | 2019-11-04 | Univ Ramot | Células madre mesenquimatosas para el tratamiento de enfermedades del SNC |
US8969081B2 (en) * | 2008-12-10 | 2015-03-03 | The Trustees Of Columbia University In The City Of New York | Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid |
WO2010075500A1 (en) | 2008-12-23 | 2010-07-01 | Stemcells California, Inc | Target populations of oligodendrocyte precursor cells and methods of making and using same |
US20100209399A1 (en) * | 2009-02-13 | 2010-08-19 | Celavie Biosciences, Llc | Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects |
US8642334B2 (en) | 2009-02-17 | 2014-02-04 | Memorial Sloan Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
US8323966B2 (en) * | 2009-06-25 | 2012-12-04 | Geron Corporation | Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes |
WO2011005326A1 (en) | 2009-07-09 | 2011-01-13 | Massachusetts Institute Of Technology | Methods and compositions for increased safety of stem cell-derived populations |
US11261425B2 (en) | 2009-08-12 | 2022-03-01 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
US10119120B2 (en) * | 2009-08-12 | 2018-11-06 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
US20120244567A1 (en) * | 2009-09-04 | 2012-09-27 | Buck Institute For Research On Aging | Human embryonic stem cells for high throughout drug screening |
AU2010315712B2 (en) | 2009-10-19 | 2014-04-17 | FUJIFILM Cellular Dynamics, Inc. | Cardiomyocyte production |
WO2011059920A2 (en) | 2009-11-10 | 2011-05-19 | The J. David Gladstone Institutes | Methods of generating neural stem cells |
DK3633025T3 (da) | 2009-11-12 | 2022-12-12 | Technion Res & Dev Foundation | Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand |
CA2781149A1 (en) | 2009-11-17 | 2011-05-26 | Advanced Cell Technology, Inc. | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
EP2507363A4 (en) * | 2009-12-02 | 2013-10-30 | Res Dev Foundation | SELECTION OF STEM CELL CLONES WITH DEFINED DIFFERENTIATION POSSIBILITIES |
WO2011130402A2 (en) | 2010-04-13 | 2011-10-20 | Cellular Dynamics International, Inc. | Hepatocyte production by forward programming |
CA2796616A1 (en) | 2010-04-21 | 2011-10-27 | Research Development Foundation | Methods and compositions related to dopaminergic neuronal cells |
EP2582793B1 (en) | 2010-06-15 | 2017-09-06 | Cellular Dynamics International, Inc. | A compendium of ready-built stem cell models for interrogation of biological response |
AU2011268056B2 (en) | 2010-06-18 | 2014-04-24 | Cellular Dynamics International, Inc. | Cardiomyocyte medium with dialyzed serum |
JP5897002B2 (ja) | 2010-07-07 | 2016-04-13 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | プログラミングによる内皮細胞の産生 |
EP2593117B1 (en) | 2010-07-12 | 2019-03-20 | University of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
US20130108589A1 (en) * | 2010-07-22 | 2013-05-02 | Affiliated Hospital Of Ningxia Medical University | Method of Producing Neurons from Stem Cells, the Neurons and Uses Thereof |
CA2805773A1 (en) * | 2010-07-30 | 2012-02-02 | Cambridge Enterprise Limited | Corticogenesis of human pluripotent cells |
CA2806858C (en) | 2010-08-04 | 2021-06-15 | Cellular Dynamics International, Inc. | Reprogramming immortalized b cells |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
US20140082758A1 (en) * | 2010-11-05 | 2014-03-20 | The Board Of Trustees Of The Leland Stanford Junior University | Control and Characterization of Psychotic States |
CN109749996A (zh) * | 2011-01-12 | 2019-05-14 | 城户常雄 | 获得和维持纯化或富集的哺乳动物神经干细胞群和/或神经祖细胞群的培养方法 |
CA2826386C (en) | 2011-02-08 | 2020-04-28 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
US20140051085A1 (en) * | 2011-03-01 | 2014-02-20 | The Scripps Research Institute | Direct reprogramming of human fibroblasts to functional neurons under defined conditions |
US20140329314A1 (en) | 2011-03-29 | 2014-11-06 | Christopher O'Sullivan | Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells |
CA2831609C (en) | 2011-03-30 | 2019-06-11 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
CA2841165A1 (en) | 2011-07-11 | 2013-01-17 | Cellular Dynamics International, Inc. | Methods for cell reprogramming and genome engineering |
CN102899285A (zh) * | 2011-07-29 | 2013-01-30 | 复旦大学 | 一种体外诱导胚胎干细胞分化成为神经细胞方法 |
CA2841985C (en) | 2011-07-29 | 2019-09-17 | Cellular Dynamics International, Inc. | Metabolic maturation in stem cell-derived tissue cells |
KR102581669B1 (ko) | 2011-11-04 | 2023-09-22 | 메모리얼 슬로안 케터링 캔서 센터 | 생착용 중뇌 도파민(da) 뉴런 |
US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
US9447378B2 (en) | 2012-04-27 | 2016-09-20 | Massachusetts Institute Of Technology | Method for differentiating human embryonic stem cells into β-cells for the treatment of type I diabetes |
EP2938721B1 (en) * | 2012-12-28 | 2019-10-16 | Kyoto University | Method for inducing astrocytes |
EP3766962A1 (en) * | 2013-02-06 | 2021-01-20 | University of Rochester | Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders |
CN105229144A (zh) | 2013-02-22 | 2016-01-06 | 细胞动力学国际有限公司 | 通过组合的遗传工程和化学工程经由正向编程产生肝细胞 |
CA3143449A1 (en) | 2013-03-14 | 2014-09-25 | The Regents Of The University Of California | In vitro production of medial ganglionic eminence precursor cells |
EP2981605B1 (en) | 2013-04-03 | 2019-06-19 | FUJIFILM Cellular Dynamics, Inc. | Methods and compositions for culturing endoderm progenitor cells in suspension |
AU2014256876B2 (en) | 2013-04-26 | 2020-11-12 | Cornell, University | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
US10119122B2 (en) | 2013-06-10 | 2018-11-06 | Academisch Ziekenhuis Leiden | Differentiation and expansion of endothelial cells from pluripotent stem cells and the in vitro formation of vasculature like structures |
KR102523912B1 (ko) | 2013-06-11 | 2023-04-21 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | SC-β 세포 및 조성물 그리고 그 생성 방법 |
US9816070B2 (en) | 2013-06-14 | 2017-11-14 | Massachusetts Institute Of Technology | Articles and methods for stem cell differentiation |
AU2014316100B2 (en) * | 2013-09-05 | 2020-11-05 | Eisai R&D Management Co., Ltd. | New method for inducing dopamine-producing neural precursor cells |
CA2926575C (en) * | 2013-10-14 | 2023-01-31 | Hadasit Medical Research Services & Development Limited | Method of obtaining terminally differentiated neuronal lineages and uses thereof |
EP3068866B1 (en) | 2013-11-16 | 2018-04-25 | Terumo BCT, Inc. | Expanding cells in a bioreactor |
IL298654A (en) | 2013-11-21 | 2023-01-01 | Memorial Sloan Kettering Cancer Center | Characterization of the origin of a functional cranial placode from human pluripotent stem cells |
ES2939807T3 (es) | 2014-03-21 | 2023-04-27 | Fujifilm Cellular Dynamics Inc | Producción de neuronas dopaminérgicas del mesencéfalo y métodos para su utilización |
EP3613841B1 (en) | 2014-03-25 | 2022-04-20 | Terumo BCT, Inc. | Passive replacement of media |
US20170107486A1 (en) | 2014-04-21 | 2017-04-20 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
ES2730325T3 (es) | 2014-04-24 | 2019-11-11 | Univ Texas | Aplicación de citoblastos pluripotentes inducidos para generar productos de terapia celular adoptiva |
JP6766032B2 (ja) * | 2014-07-31 | 2020-10-07 | ユニヴェルシテ デクス−マルセイユUniversite D’Aix−Marseille | ニューロン細胞及び筋細胞を産生するための方法 |
CN106715676A (zh) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | 按计划供养 |
WO2016061071A1 (en) | 2014-10-14 | 2016-04-21 | Cellular Dynamics International, Inc. | Generation of keratinocytes from pluripotent stem cells and mantenance of keratinocyte cultures |
CN105624116B (zh) * | 2014-11-07 | 2020-04-07 | 中国科学院上海生命科学研究院 | 利用多能干细胞制备神经前体细胞的方法 |
US10190096B2 (en) | 2014-12-18 | 2019-01-29 | President And Fellows Of Harvard College | Methods for generating stem cell-derived β cells and uses thereof |
US10443042B2 (en) | 2014-12-18 | 2019-10-15 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof |
WO2016100930A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Methods for generating stem cell-derived b cells and methods of use thereof |
US9724432B2 (en) | 2015-04-30 | 2017-08-08 | University Of Rochester | Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder |
HUE058258T2 (hu) * | 2015-06-01 | 2022-07-28 | Memorial Sloan Kettering Cancer Center | Középagyi dopamin (mda) neuronok in vitro differenciálódásának eljárásai |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US10384207B2 (en) | 2015-07-21 | 2019-08-20 | Neuro Probe Incorporated | Assay apparatus and methods |
AU2016321170B2 (en) | 2015-09-08 | 2022-09-01 | Fujifilm Cellular Dynamics | Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells |
CA2997763A1 (en) | 2015-09-08 | 2017-03-16 | Cellular Dynamics International, Inc. | Macs-based purification of stem cell-derived retinal pigment epithelium |
CA3001316A1 (en) | 2015-10-08 | 2017-04-13 | Neurona Therapeutics Inc. | Neural precursor cell populations and uses thereof |
MX2018005274A (es) | 2015-10-30 | 2019-09-19 | The Regents Of The Universtiy Of California | Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t. |
EP3436567A4 (en) | 2016-03-30 | 2019-10-30 | Asterias Biotherapeutics, Inc. | OLIGODENDROCYTE PROGENITOR CELL COMPOSITIONS |
US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
EP3500664B1 (en) | 2016-08-16 | 2021-09-22 | FUJIFILM Cellular Dynamics, Inc. | Methods for differentiating pluripotent cells |
JP7471084B2 (ja) * | 2017-03-21 | 2024-04-19 | メモリアル スローン ケタリング キャンサー センター | 幹細胞由来星状細胞、作製方法および使用方法 |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
EP3656841A1 (en) | 2017-03-31 | 2020-05-27 | Terumo BCT, Inc. | Cell expansion |
JP7457505B2 (ja) | 2017-05-10 | 2024-03-28 | ユニバーシティー オブ ロチェスター | 神経精神障害を処置する方法 |
BR112020009275A2 (pt) | 2017-11-15 | 2020-10-27 | Semma Therapeutics, Inc. | composições de fabricação de célula de ilhota e métodos de uso |
CN112204134A (zh) | 2018-04-20 | 2021-01-08 | 富士胶片细胞动力公司 | 眼细胞的分化方法及其用途 |
RU2690846C1 (ru) * | 2018-05-17 | 2019-06-06 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр" | Ноотропная композиция на основе полипептидных комплексов, выделенных из нейронов и глиальных клеток, полученных методом направленной дифференцировки индуцированных плюрипотентных стволовых клеток человека |
RU2690498C1 (ru) * | 2018-05-17 | 2019-06-04 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр" | Способ получения ноотропной композиции на основе полипептидных комплексов, выделенных из нейронов и глиальных клеток, полученных методом направленной дифференцировки индуцированных плюрипотентных стволовых клеток человека |
WO2020033879A1 (en) | 2018-08-10 | 2020-02-13 | Semma Therapeutics, Inc. | Stem cell derived islet differentiation |
EP3883617A1 (en) | 2018-11-19 | 2021-09-29 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Biodegradable tissue replacement implant and its use |
KR20200077222A (ko) | 2018-12-20 | 2020-06-30 | (주)영인바이오텍 | 통증완화부를 가지는 회복 운동 장치 |
KR20200077218A (ko) | 2018-12-20 | 2020-06-30 | (주)영인바이오텍 | 교체가능한 부품을 가지는 회복 운동 장치 |
WO2020153687A1 (ko) * | 2019-01-22 | 2020-07-30 | 고려대학교 산학협력단 | 직접 세포전환을 기반으로한 신경줄기세포의 성상교세포로의 분화방법 |
JP2022526591A (ja) * | 2019-04-03 | 2022-05-25 | ザ ジョンズ ホプキンス ユニバーシティ | 骨格筋幹細胞の製造及び障害の治療のための方法、組成物及びキット |
EP3792346B1 (en) | 2019-09-13 | 2023-07-26 | Miltenyi Biotec B.V. & Co. KG | Method for the generation of a cell composition of ventral midbrain dopaminergic progenitor cells |
JP2023501520A (ja) | 2019-11-14 | 2023-01-18 | アムジエン・インコーポレーテツド | 造血前駆細胞の産生 |
AU2020392124A1 (en) * | 2019-11-25 | 2022-06-16 | The Penn State Research Foundation | Composition and method for converting human glial cells into neurons |
RU2732599C1 (ru) * | 2019-12-26 | 2020-09-21 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр имени академика Н.П. Бочкова" | Ноотропная композиция на основе полипептидных комплексов, выделенных из глиальных прогениторных клеток в условиях теплового шока, и способ её получения |
RU2732600C1 (ru) * | 2019-12-26 | 2020-09-21 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр имени академика Н.П. Бочкова" | Ноотропная композиция на основе полипептидных комплексов, выделенных из нейрональных прогениторных клеток в условиях гипоксии, и способ ее получения |
RU2752906C2 (ru) * | 2019-12-26 | 2021-08-11 | Федеральное государственное бюджетное научное учреждение "Медико-генетический научный центр имени академика Н.П. Бочкова" | Ноотропная композиция на основе полипептидных комплексов, выделенных из нейрональных прогениторных клеток в условиях теплового шока, и способ ее получения |
BR112022024064A2 (pt) | 2020-05-29 | 2023-01-31 | Fujifilm Cellular Dynamics Inc | Bicamada de epitélio pigmentado da retina e fotorreceptores e uso dos mesmos |
KR20230019453A (ko) | 2020-05-29 | 2023-02-08 | 후지필름 셀룰러 다이내믹스, 인코포레이티드 | 망막 색소 상피 세포 및 광수용체의 이중 세포 응집체 및 이의 사용 방법 |
US12043823B2 (en) | 2021-03-23 | 2024-07-23 | Terumo Bct, Inc. | Cell capture and expansion |
CA3213988A1 (en) | 2021-04-07 | 2022-10-13 | Christopher MCMAHON | Dopaminergic precursor cells and methods of use |
US20240271089A1 (en) | 2021-05-28 | 2024-08-15 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Methods to generate macular, central and peripheral retinal pigment epithelial cells |
US20240261474A1 (en) | 2021-05-28 | 2024-08-08 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Biodegradable tissue scaffold with secondary matrix to host weakly adherent cells |
CN116478923B (zh) * | 2022-04-26 | 2024-01-02 | 浙江霍德生物工程有限公司 | 一种星形胶质细胞的制备方法 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE239072T1 (de) | 1991-06-18 | 2003-05-15 | Arnold I Caplan | Menschliche mesenchym-stammzellen aus dem mark und monoklonale antikörper spezifisch gegen diese zellen |
AU2228592A (en) | 1991-06-24 | 1993-01-25 | Pacific Biomedical Research, Inc. | Hormone-secreting cells maintained in long-term culture |
US5981165A (en) * | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | In vitro induction of dopaminergic cells |
EP0594669B9 (en) | 1991-07-08 | 2008-03-19 | NeuroSpheres Holdings Ltd. | Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
EP0597964A4 (en) * | 1991-08-07 | 1994-11-30 | Einstein Coll Med | PROLIFERATION OF HEPATOCYTE PRECURSORS. |
US5693482A (en) * | 1992-07-27 | 1997-12-02 | California Institute Of Technology | Neural chest stem cell assay |
US5849553A (en) * | 1992-07-27 | 1998-12-15 | California Institute Of Technology | Mammalian multipotent neural stem cells |
AU4995193A (en) | 1992-08-04 | 1994-03-03 | Regeneron Pharmaceuticals, Inc. | Method of enhancing differentiation and survival of neuronal precursor cells |
US5766948A (en) * | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
US5534404A (en) * | 1993-12-10 | 1996-07-09 | Cytotherapeutics, Inc. | Glucose responsive insulin secreting β-cell lines and method for producing same |
US5639618A (en) * | 1994-05-13 | 1997-06-17 | Plurion, Inc. | Method of isolating a lineage specific stem cell in vitro |
US5476975A (en) * | 1994-07-08 | 1995-12-19 | Ruddick; John N. R. | Extraction of toxic organic contaminants from wood and photodegradation of toxic organic contaminants |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9807935D0 (en) * | 1998-04-14 | 1998-06-10 | Univ Edinburgh | Lineage specific cells and progenitor cells |
US5753506A (en) * | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
US6090622A (en) * | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
US6361996B1 (en) * | 1997-05-07 | 2002-03-26 | University Of Utah Research Foundation | Neuroepithelial stem cells and glial-restricted intermediate precursors |
IL133799A0 (en) * | 1997-07-04 | 2001-04-30 | Univ Utah Res Found | Lineage-restricted neuronal precursors |
US6235527B1 (en) * | 1997-11-29 | 2001-05-22 | University Of Utah Research Foundation | Lineage restricted glial precursors from the central nervous system |
US7144997B2 (en) | 1997-07-24 | 2006-12-05 | Curis, Inc. | Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
AU1197699A (en) | 1997-10-23 | 1999-05-10 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
DE19756864C5 (de) * | 1997-12-19 | 2014-07-10 | Oliver Brüstle | Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten |
EP1056835A4 (en) | 1998-02-27 | 2003-01-15 | Hampton Roads Medical College | DERIVATION OF CELLS AND TISSUES FROM THE PRE-STRAINED CELL STAGE FOR TRANSPLANTATION THERAPIES |
WO1999053021A1 (en) | 1998-04-09 | 1999-10-21 | Bresagen Limited | Cell differentiation/proliferation and maintenance factor and uses thereof |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
DE19843234A1 (de) * | 1998-09-09 | 2000-03-23 | Inst Pflanzengenetik & Kultur | Differenzierte Herzzellen mit pathologischen Merkmalen als in vitro-Modell für Herzerkrankungen |
ES2587189T3 (es) | 1998-09-22 | 2016-10-21 | Neuralstem, Inc. | Líneas de células madre neurales estables |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US6087168A (en) * | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
ES2295012T3 (es) | 1999-02-12 | 2008-04-16 | Stemcells California, Inc. | Poblaciones enriquecidas de celulas del sistema nervioso central. |
US6238922B1 (en) * | 1999-02-26 | 2001-05-29 | Stemcells, Inc. | Use of collagenase in the preparation of neural stem cell cultures |
EP1165771A2 (en) | 1999-03-17 | 2002-01-02 | The University Of Tennessee Research Corporation | Rt-pcr of clonal neurospheres |
IL147179A0 (en) | 1999-06-30 | 2002-08-14 | Advanced Cell Tech Inc | Cytoplasmic transfer to de-differentiate recipient cells |
WO2001046384A2 (en) * | 1999-12-23 | 2001-06-28 | Cornell Research Foundation, Inc. | A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells |
US20050042749A1 (en) * | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
US6602711B1 (en) * | 2000-02-21 | 2003-08-05 | Wisconsin Alumni Research Foundation | Method of making embryoid bodies from primate embryonic stem cells |
IL151170A0 (en) * | 2000-03-14 | 2003-04-10 | Es Cell Int Pte Ltd | Embryonic stem cells and neural progenitor cells derived therefrom |
US6458589B1 (en) * | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
AU2001259323A1 (en) | 2000-05-01 | 2001-11-12 | Sang-Hun Lee | Derivation of midbrain dopaminergic neurons from embryonic stem cells |
US8273570B2 (en) * | 2000-05-16 | 2012-09-25 | Riken | Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells |
US7250294B2 (en) * | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
JP5943533B2 (ja) * | 2000-05-17 | 2016-07-06 | アステリアス バイオセラピューティクス インコーポレイテッド | 神経前駆細胞の集団 |
WO2001098463A1 (en) | 2000-06-20 | 2001-12-27 | Es Cell International Pte Ltd | Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists |
JP3660601B2 (ja) | 2001-03-30 | 2005-06-15 | 独立行政法人科学技術振興機構 | 胚性幹細胞からの神経幹細胞、運動ニューロン及びgaba作動性ニューロンの製造法 |
US20040247571A1 (en) | 2001-04-23 | 2004-12-09 | Xia Meijer | Neural cells expressing tyrosine hydroxylase |
US20030113910A1 (en) * | 2001-12-18 | 2003-06-19 | Mike Levanduski | Pluripotent stem cells derived without the use of embryos or fetal tissue |
US7285415B2 (en) | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US7629169B2 (en) * | 2004-12-01 | 2009-12-08 | Stem Cell Therapeutics Corp. | Methods for the production of platelet-derived growth factor-responsive neural precursor cells |
-
2001
- 2001-05-16 JP JP2001585312A patent/JP5943533B2/ja not_active Expired - Lifetime
- 2001-05-16 AU AU6319901A patent/AU6319901A/xx active Pending
- 2001-05-16 CN CN01809662A patent/CN100580079C/zh not_active Expired - Fee Related
- 2001-05-16 GB GB0229369A patent/GB2379447B/en not_active Expired - Lifetime
- 2001-05-16 EP EP01937463A patent/EP1287116A2/en not_active Withdrawn
- 2001-05-16 US US09/859,351 patent/US20020009743A1/en not_active Abandoned
- 2001-05-16 AU AU2001263199A patent/AU2001263199B2/en not_active Expired
- 2001-05-16 CA CA2409698A patent/CA2409698C/en not_active Expired - Lifetime
- 2001-05-16 IL IL15274101A patent/IL152741A0/xx active IP Right Grant
- 2001-05-16 KR KR1020027015192A patent/KR100903755B1/ko active IP Right Grant
- 2001-05-16 WO PCT/US2001/015861 patent/WO2001088104A2/en active Application Filing
- 2001-05-31 US US09/872,183 patent/US6833269B2/en not_active Expired - Lifetime
-
2002
- 2002-11-10 IL IL152741A patent/IL152741A/en unknown
-
2003
- 2003-11-11 HK HK03108154.2A patent/HK1055765A1/xx not_active IP Right Cessation
-
2005
- 2005-11-16 US US11/281,040 patent/US8148148B2/en not_active Expired - Fee Related
-
2008
- 2008-12-11 US US12/332,783 patent/US8252585B2/en not_active Expired - Lifetime
-
2012
- 2012-07-25 US US13/558,078 patent/US9803174B2/en not_active Expired - Fee Related
- 2012-11-29 JP JP2012260896A patent/JP5685242B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-26 JP JP2013268201A patent/JP2014110790A/ja active Pending
-
2014
- 2014-03-18 US US14/217,699 patent/US20140242691A1/en not_active Abandoned
-
2016
- 2016-03-10 JP JP2016047121A patent/JP2016146839A/ja active Pending
-
2017
- 2017-08-17 JP JP2017157484A patent/JP6644277B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100580079C (zh) | 神经祖细胞群体 | |
CN100384986C (zh) | 用于治疗帕金森病的多巴胺能神经元和具有增殖能力的前体细胞 | |
Imura et al. | Phenotypic and functional heterogeneity of GFAP‐expressing cells in vitro: Differential expression of LeX/CD15 by GFAP‐expressing multipotent neural stem cells and non‐neurogenic astrocytes | |
CN103396993B (zh) | 衍生自灵长类胚胎干细胞的用于脊髓损伤的再髓鞘化和治疗的少突胶质细胞 | |
CN103146649B (zh) | 神经干细胞 | |
AU2001263199A1 (en) | Neural progenitor cell populations | |
JP2001526884A (ja) | 神経前駆細胞、その製造方法および神経性欠陥治療におけるその使用 | |
JP5159804B2 (ja) | パーキンソン病を治療するためのドーパミン作動性ニューロンおよび増殖能のある前駆細胞 | |
CN101124319A (zh) | 神经干细胞 | |
US7763463B2 (en) | Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells | |
Glass et al. | Brain organoids: models of cell type diversity, connectivity, and disease phenotypes | |
AU2004214542B2 (en) | Neural progenitor cell populations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1055765 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: ASTERLIAS BIOTHERAPY CO., LTD. Free format text: FORMER OWNER: GERON CORP. Effective date: 20140523 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140523 Address after: American California Patentee after: ASTERIAS BIOTHERAPY CORP. Address before: American California Patentee before: Geron Corp. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100113 Termination date: 20200516 |